{"meshTags":["Lung Neoplasms","Humans","Receptor, Platelet-Derived Growth Factor alpha","Antineoplastic Agents","Clinical Trials as Topic","Receptor Protein-Tyrosine Kinases","Proto-Oncogene Proteins c-met","Receptor, Fibroblast Growth Factor, Type 1","Proto-Oncogene Proteins","Carcinoma, Non-Small-Cell Lung","Ephrins"],"meshMinor":["Lung Neoplasms","Humans","Receptor, Platelet-Derived Growth Factor alpha","Antineoplastic Agents","Clinical Trials as Topic","Receptor Protein-Tyrosine Kinases","Proto-Oncogene Proteins c-met","Receptor, Fibroblast Growth Factor, Type 1","Proto-Oncogene Proteins","Carcinoma, Non-Small-Cell Lung","Ephrins"],"genes":["FGFR","ephrins","Mer","MET","PDGFR-α"],"publicationTypes":["Journal Article"],"title":"Targeting FGFR, ephrins, Mer, MET, and PDGFR-α in non-small cell lung cancer.","pubmedId":"22005534"}